AceBiome, a dietary supplements company supplying probiotics products based on microbiome research, spun out of Bioneer Corporation in 2017 and was founded as a subsidiary of Bioneer.
Lactobacillus gasser BNR17′, researched and developed for about twenty years by the researchers of Bioneer and AceBiome, is the first probiotic strain approved by MFDS (Korea FDA) as a functional ingredient to help reduce body fat, and is currently a globally patented probiotic for weight control and diabetes.
Centered around BNR17′ probiotic products that ameliorate overweight and obesity, AceBiome is a fast-growing, global company that seeks to improve human health and quality of life.